000 | 01033 a2200301 4500 | ||
---|---|---|---|
005 | 20250513081209.0 | ||
264 | 0 | _c19930504 | |
008 | 199305s 0 0 eng d | ||
022 | _a0092-6019 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDiamantstein, T | |
245 | 0 | 0 |
_aInterleukin-2 receptor-targeted immune therapy. _h[electronic resource] |
260 |
_bImmunology series _c1993 |
||
300 |
_a295-318 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
650 | 0 | 4 |
_aAutoimmune Diseases _xtherapy |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xtherapy |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xtherapy |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aInterleukin-2 _ximmunology |
650 | 0 | 4 |
_aPancreas _ximmunology |
650 | 0 | 4 |
_aPancreas Transplantation _ximmunology |
650 | 0 | 4 |
_aReceptors, Interleukin-2 _ximmunology |
700 | 1 | _aHahn, H J | |
773 | 0 |
_tImmunology series _gvol. 59 _gp. 295-318 |
|
999 |
_c8460666 _d8460666 |